| Colorectal cancer in the young: epidemiology, prevention, management. RL Siegel, CD Jakubowski, SA Fedewa, A Davis, NS Azad American Society of Clinical Oncology Educational book. American Society of …, 2020 | 256 | 2020 |
| Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection R Sinha, AG Winer, M Chevinsky, C Jakubowski, YB Chen, Y Dong, ... Nature communications 8 (1), 1-10, 2017 | 75 | 2017 |
| Pathological stage T3a significantly increases disease recurrence across all tumor sizes in renal cell carcinoma M Chevinsky, M Imnadze, A Sankin, A Winer, R Mano, C Jakubowski, ... The Journal of urology 194 (2), 310-315, 2015 | 57 | 2015 |
| Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma) CD Jakubowski, NS Azad Chinese Clinical Oncology 9 (1), 2-2, 2020 | 50 | 2020 |
| Complete metastasectomy for renal cell carcinoma: comparison of five solid organ sites CD Jakubowski, EA Vertosick, BR Untch, D Sjoberg, E Wei, FL Palmer, ... Journal of surgical oncology 114 (3), 375-379, 2016 | 50 | 2016 |
| Impact of ureteroscopy before nephroureterectomy for upper tract urothelial carcinoma on oncologic outcomes A Sankin, AL Tin, R Mano, M Chevinsky, C Jakubowski, JP Sfakianos, ... Urology 94, 148-153, 2016 | 41 | 2016 |
| Antibody-drug conjugates in bladder cancer PJ Vlachostergios, CD Jakubowski, MJ Niaz, A Lee, C Thomas, ... Bladder Cancer 4 (3), 247-259, 2018 | 38 | 2018 |
| iTriplet, a rule-based nucleic acid sequence motif finder ES Ho, CD Jakubowski, SI Gunderson Algorithms for Molecular Biology 4, 1-14, 2009 | 30 | 2009 |
| Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma R Mano, E Vertosick, AI Sankin, MS Chevinsky, Y Larish, CD Jakubowski, ... The Journal of urology 193 (3), 776-782, 2015 | 25 | 2015 |
| U1 adaptor oligonucleotides targeting BCL2 and GRM1 suppress growth of human melanoma xenografts in vivo R Goraczniak, BA Wall, MA Behlke, KA Lennox, ES Ho, NH Zaphiros, ... Molecular Therapy-Nucleic Acids 2, 2013 | 13 | 2013 |
| A phase I/II study of PI3Kinase inhibition with copanlisib combined with the anti-PD-1 antibody nivolumab in relapsed/refractory solid tumors with expansions in MSS colorectal … C Jakubowski, NB Collins, EA Sugar, M Berg, H Cao, M Giannakis, ... Journal of Clinical Oncology 38 (15_suppl), TPS4114-TPS4114, 2020 | 11 | 2020 |
| Response to crizotinib in ROS1 fusion–positive intrahepatic cholangiocarcinoma CD Jakubowski, AA Mohan, IR Kamel, M Yarchoan JCO Precision Oncology 4, 2020 | 9 | 2020 |
| Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection. Nat Commun. 2017; 8: 15165 R Sinha, AG Winer, M Chevinsky, C Jakubowski, YB Chen, Y Dong, ... | 6 | |
| VENTRAL INTRALESIONAL VERAPAMIL INJECTIONS FOR PEYRONIE'S DISEASE: FEASABILITY AND SAFETY B Berookhim, M Chevinsky, C Jakubowski, Y Larish, C Nelson, J Mulhall JOURNAL OF SEXUAL MEDICINE 12, 6-6, 2015 | 4 | 2015 |
| RussoP (2016) Completemetastasectomyforrenal cell carcinoma: Comparison of five solid organ sites CD Jakubowski, EA Vertosick, BR Untch, D Sjoberg, E Wei, FL Palmer, ... JSurgOncol114 (3), 375-379, 0 | 4 | |
| Trimodality therapy in variant urothelial carcinoma: choose wisely PJ Vlachostergios, C Jakubowski, ST Tagawa Translational Andrology and Urology 6 (2), 322, 2017 | 3 | 2017 |
| MP59-02 IMPACT OF URETEROSCOPY PRIOR TO NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA ON ONCOLOGIC OUTCOMES A Sankin, A Tin, R Mano, M Chevinsky, C Jakubowski, E Cha, A Yee, ... The Journal of Urology 193 (4S), e729-e730, 2015 | 2 | 2015 |
| Clinical and molecular features of adenosquamous pancreatic cancer (ASQ): A distinct histological subtype. C Jakubowski, SJ Lim, A Pellatt, H Wang, RA Burkhart, E Thompson, ... Journal of Clinical Oncology 39 (3_suppl), 426-426, 2021 | 1 | 2021 |
| A phase II trial of PD-1 inhibition with INCMGA00012 in patients with previously treated unresectable or metastatic adenosquamous pancreatic cancer. C Jakubowski, ED Thompson, H Wang, R Walker, EM Jaffee, NS Azad Journal of Clinical Oncology 38 (15_suppl), TPS4662-TPS4662, 2020 | 1 | 2020 |
| U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo R Goraczniak, BA Wall, MA Behlke, KA Lennox, ES Ho, NH Zaphiros, ... Molecular Therapy Nucleic Acids 36 (1), 2025 | | 2025 |
